BenevolentAI’s co-founder is back. Here’s how he plans a turnaround at the AI company during a ‘pivotal time’

Can Ken Mulvany save BenevolentAI?

About a decade ago, Mulvany helped found the company as part of the first generation of AI-focused biotech startups. It …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Renck & File: Nuggets MVP Nikola Jokic has never ridden a horse. Wait, come again? – The Cannabist

It took a camel for us to find out Nikola Jokic has never ridden a horse. The Nuggets spent this week in Abu Dhabi playing

October 5, 2024

AstraZeneca hopes to make clinical trial operations carbon-negative by 2030

AstraZeneca has spoken about how they are delivering ambitious plans to help other pharma companies follow suit. Image credit: AstraZeneca. AstraZeneca has big plans to

September 6, 2023

Researchers uncover the role of glutaminase 2 in glucose homeostasis

Glutaminase 2 (GLS2) is a master regulator of glutaminolysis. GLS2 converts glutamine to glutamate, thereby playing a role in cellular energy production. GLS2 is abundant

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.